ストックスクリーナーアプリを入手
4.19
12.89%
-0.62
プレマーケット:
4.07
-0.12
-2.86%
前日終値:
$4.81
開ける：
$4.74
24時間の取引高:
115.66K
Relative Volume:
2.33
時価総額：
$23.57M
収益：
$257.00K
当期純損益:
$-3.07M
株価収益率:
-4.398
EPS:
-0.9527
ネットキャッシュフロー:
$-1.40M
1週間 パフォーマンス:
-14.75%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$4.03
$4.80
1週間の範囲:
$4.00
$5.13
52週間の値動き範囲:
$4.00
$6.20
Optimi Health Corp Stock (OPTH) Company Profile
Compare OPTH vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OPTH
Optimi Health Corp
|
4.19 | 27.06M | 257.00K | -3.07M | -1.40M | -0.9527 |
TAK
Takeda Pharmaceutical Co Adr
|
15.66 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.09 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.33 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
548.27 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Optimi Health Corp (OPTH) 最新ニュース
Optimi Health (OPTH) Earnings Date and Reports 2026 - MarketBeat
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits
Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel - Yahoo Finance
Optimi Health ships psilocybin to UK for clinical trial By Investing.com - Investing.com Australia
Optimi Health ships psilocybin to UK for clinical trial - Investing.com
Optimi Health Completes First Psilocybin Export to UK for Planned Phase 2 Trial - citybuzz -
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial - PR Newswire
Optimi Health exports psilocybin to UK for clinical trial By Investing.com - Investing.com South Africa
Optimi Health exports psilocybin to UK for clinical trial - Investing.com UK
Optimi Health Completes First Export of Psilocybin to UK - marketscreener.com
Optimi Health Corp. Completes First Export of Psilocybin to the UK for Phase 2 Clinical Trial - Quiver Quantitative
OPTH SEC FilingsOptimi Health 10-K, 10-Q, 8-K Forms - Stock Titan
Optimi Health Corp. (OPTH) Price Book Value - Zacks Investment Research
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development - The Malaysian Reserve
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Weekly Voice
Optimi Health stock surges on ibogaine supply deal By Investing.com - Investing.com Australia
Optimi Health stock surges on ibogaine supply deal - Investing.com
US order prioritizes ibogaine; Optimi Health builds GMP supply in Canada - Stock Titan
OPTH Stock Chart | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
OPTH Technical Analysis | Trend, Signals & Chart Patterns | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
Optimi Health Corp.Common Shares (Nasdaq:OPTH) Stock Quote - FinancialContent
Optimi Health (OPTH) Stock Forecast and Price Target 2026 - MarketBeat
Optimi Health completes GMP production of psilocybin capsules By Investing.com - Investing.com Canada
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia - PR Newswire Canada
Optimi Health completes GMP production of psilocybin capsules - Investing.com UK
OPTH | Optimi Health Corp. Common Institutional Ownership - Quiver Quantitative
OPTH Stock Price, Quote & Chart | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
OPTH News | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
Psilocybin pills prescribed for hard-to-treat depression in Australia - Stock Titan
Price to book ratio of Optimi Health Corp. – DUS:8BN0 - TradingView
Optimi Health (OPTH) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update - NewMediaWire
What is the current Price Target and Forecast for Optimi Health Corp. (OPTH) - Zacks Investment Research
Optimi Health Corp (OPTH) 財務データ
収益
当期純利益
現金流量
EPS
2.11%
大文字化:
|
ボリューム (24 時間):